Skip over main navigation
  • Sign up
  • Log in
  • Basket: (0 items)
Emerge Australia
  • Twitter
  • Facebook
  • Email
Donate Become a member
Menu
  • About us
    • What we do
    • Our team
    • Our Ambassador
    • Our impact
    • Annual reports
    • Contact us
  • ME/CFS information
    • What is ME/CFS?
    • Diagnosis
    • Treatment and management
    • What is fibromyalgia?
    • ME/CFS - what's in a name?
    • For health professionals
    • Member stories
  • Research
    • OMF Australia
    • ME/CFS biobank and registry
    • ANCHOR Study
    • Research Digest
    • Health and Wellbeing Survey
  • How to get help
    • InfoLine
    • Telehealth Nurse Service
    • Online Community
    • Accessing financial support
      • About NDIS
      • About DSP
      • Financial literacy resources for ME/CFS
  • Get involved
    • Give monthly
    • Donate
    • Fundraisers
    • Bequest giving
    • Emerge Australia Membership
    • Volunteer with us
    • Patient Advisory Group
    • Campaigns and advocacy resources
    • ME/CFS Awareness Day
  • Shop
  • News
    • News
  • Admin
    • Log in
  • Basket: (0 items)
  • Open Medicine Foundation Australia
  1. Research
  2. OMF Australia

Open Medicine Foundation Australia

Established in October 2020, Open Medicine Foundation Australia (OMF Australia) is an Australian foundation set up to support biomedical research through the establishment of a new ME/CFS collaborative research centre in Australia. OMF Australia was founded by Emerge Australia in partnership with the Open Medicine Foundation, meaning that Australia is now part of the largest, concerted worldwide non-profit effort to diagnose, treat and find a cure for ME/CFS.

Sign up for research updates

The Australian centre is directed by Christopher Armstrong, PhD, and seeks to develop a disease management and treatment approach that focuses on the individual patient and the biology that underlies their disease. The research will look for unifying biological pathways of ME/CFS that cause the disease experience to be the same between patients, while also identifying biological aspects that produce different disease experiences between patients.

"I am thrilled that OMF has decided to expand its global ME/CFS research network to Australia,” Dr Armstrong said. “This will be the fifth Collaborative Research Centre (CRC) of this network and I am absolutely honoured to be the director.

"Over the past couple years I have been working with the other CRC directors, observing the great research at Stanford, Harvard, Uppsala and Montreal and I'm excited to bring the excellent Australian research community to the fold."

“It was clear to us at Emerge Australia that there has been a real need to find a way for people with ME/CFS, and for the wider community, to be able to donate to high quality biomedical research into ME/CFS here in Australia,” explained Emerge Australia CEO Dr Heidi Nicholl.

“Partnering with Open Medicine Foundation to establish OMF Australia made sense to us in a lot of ways. They have already established research centres around the world and we love the whole ethos of scientists openly sharing their results with one another.

"Developing a diagnostic test and finding effective treatments will hopefully come

along the way, but they want a cure. And we want that too."

“We also love that they are completely explicit about being in this to find a cure. Developing a diagnostic test and finding effective treatments will hopefully come along the way, but they want a cure. And we want that too.

“They have all their systems worked out already including a scientific advisory board that includes two Nobel laureates. The other thing was connecting Australia into this international network. It helps for everybody to raise the profile of home-grown researchers. Finally they’re just incredibly kind and easy to work with. We love OMF and they made this process so easy for us.”

Dr Chris Armstrong

Chris Armstrong, PhD, is OMF’s former Science Liaison and Visiting Scholar at Stanford University and has been involved with researching ME/CFS for more than a decade. An Australian native, he is perfectly positioned to lead and grow this new research hub for years to come.

Dr Armstrong is most well-known for his research using metabolomics to observe biochemical alterations in ME/CFS patients. He began his work in this field at the University of Melbourne, completing his PhD in applying metabolomics to study ME/CFS. He published his first ME/CFS metabolomics study on blood and urine in 2015.

Since then he has set up collaborative efforts to apply metabolomics to immunological experiments on ME/CFS, observing how metabolism may relate to immune cell function. He has also focused on longitudinal research while looking to extend metabolic capabilities across the field of ME/CFS to help collate different patient groups.

Under Dr Armstrong’s direction, the team at OMFA will conduct a ground-breaking research program to develop a personalised medicine approach for studying and treating ME/CFS.

In its first project his team will deeply characterise the biology of people with ME/CFS by continuously monitoring their health data and sporadically sampling and analysing their blood and urine over the course of a year. Data will be analysed to identify characteristics of disease severity in individuals, then compared across patients to identify patterns – helping to reduce the complexity and length of the personalised medicine approach.

The expected outcome is the establishment of a condensed personalised research method that can be used to track the development of ME/CFS, provide an understanding of the biology of the disease process in the individual, and monitor outcomes in treatment trials.

We look forward to providing you with periodic updates on OMFA and the progress of the Australian research centre, through our newsletters. Click here to donate to Help Cure ME:

Help Cure ME

Published: 21st October, 2020

Updated: 8th December, 2020

Author: Paula Gething

Related topics:
  • Australian & Global Community
Share this page
  • Email
  • Facebook
  • Twitter

Help Cure ME

Casey Stoner AM, two time MotoGP World Champion joins Emerge Australia as their new Ambassador, helping raise funds and awareness for ME/CFS, and the newly established Open Medicine Foundation Australia research centre.

Published: 22nd September, 2020

Author: Paula Gething

Location: ,,

Target amount: $0.00

Amount raised: $1,157.90

Donate

Comments: 0

Related topics:

Latest

  • Research Digest 12/02/21

    Research Digest 12/02/21

    Welcome to the 63rd edition of the Research Digest. This edition features a study investigating the impact that ME/CFS has on the quality of life of a patients' close family members, and a study identifying and measuring the epigenetic changes in the DNA of ME/CFS patients.

  • Mindful Meditation Class for People with ME/CFS - Online Group

    One of our online community classes for people with ME/CFS. Details of our online mindful meditation class for people who live with ME/CFS.

  • Mindful Doodling Class for People with ME/CFS - Online Group

    One of our online community classes for people with ME/CFS. Details of our online mindful doodling class for people who live with ME/CFS.

  • Beginners Crochet Class for People with ME/CFS - Online Group

    One of our online community classes for people with ME/CFS. Details of our online beginners crochet class for people who live with ME/CFS.

Related

  • #MEAction Network

    A global, grassroots network for people with Myalgic Encephalomyelitis and Chronic Fatigue Syndrome

  • International Alliance for ME

    International Alliance for ME

    The International Alliance for ME is a collaboration of ME organisations across the world

Most read

  • Open Medicine Foundation Australia

    Open Medicine Foundation Australia

    Emerge Australia is proud to be launching the 5th addition to a global network of OMF-established Collaborative Research Centres, with our partner, Open Medicine Foundation, seeing an Australian centre join with those at Harvard, Stanford, Uppsala, and Montreal universities.

  • Research Digest 30/10/20

    Welcome to the 58th edition of the Research Digest featuring a focus group study that aimed to gain insight into the PEM experiences of ME/CFS patients and a cluster analysis study defining subgroups of patients based on several measures of autonomic dysfunction.

  • Australian Research Centre to Open Early in 2021

    Australian Research Centre to Open Early in 2021

    The new Australian ME/CFS Centre for Collaborative Research is expected to officially open early in 2021

  • Research Digest 04/09/20

    Welcome to the 54th edition of the Research Digest. This fortnight's edition includes summary of a functional MRI study exploring brain responses to autonomic challenges in ME/CFS patients with and without temporomandibular disorder.

  • Coronavirus and ME - Simplified facts

    Coronavirus and ME - Simplified facts

    Many people with ME/CFS and other vulnerable communities in Australia are concerned about the impacts of the spreading coronavirus disease COVID-19. This is an easy-read resource with the latest information and advice.

  • Research Digest 13/11/20

    Welcome to the 59th edition of the Research Digest. This issue features a review article on the eitology of ME/CFS and a systematic review of neuroimaging studies.

  • Research Digest 16/10/20

    Welcome to the 57th edition of the Research Digest featuring the results of the NHMRC ME/CFS Targeted Call for Research funding and a study that aimed to compare the subjective severity scoring of the SF-36 (based on the physical activity subscale) to two objective measures of activity in order to validate the way in which clinical severity is graded in ME/CFS.

  • Research Digest 29/01/21

    Research Digest 29/01/21

    Welcome to the 62nd edition of the Research Digest featuring a study investigating the predictors of tachypnea in ME/CFS patients and a literature review examining GP knowledge and understanding of ME/CFS.

  • Accessibility

  • Research Digest 07/08/20

    Welcome to the 53rd edition of the Research Digest. This fortnight's edition features a ME/CFS focused edition of the journal WORK: A Journal of Prevention, Assessment and Rehabilitation.

Join our community

* indicates required


Specific mailing lists

Helpful links

  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Privacy Policy

Connect with us

  • Twitter
  • Facebook
  • YouTube


Get in touch with us

Emerge Australia
Ross House
247 - 251 Flinders Lane
Melbourne VIC 3000
1800 865 321
03 9529 1344
 

Emerge Australia is registered as a charity with the Australian Charities and Not-for-profits Commission (ACNC). We are authorised by the Australian Tax Office as a deductible gift recipient (DGR). 

ABN/DGR: 22 385 438 041

Donations of $2 or more are tax-deductible. 

Emerge Australia acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the land and pays respect to their Elders past and present.

© 2019 Emerge Australia. All rights reserved.